SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-08-024516
Filing Date
2008-04-28
Accepted
2008-04-28 16:58:00
Documents
1
Period of Report
2008-04-24

Document Format Files

Seq Description Document Type Size
1 v111903_ex.html 4  
1 v111903_ex.xml 4 3794
  Complete submission text file 0001144204-08-024516.txt   5747
Mailing Address 4225 EXECUTIVE SQUARE SUITE 460 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 460 LA JOLLA CA 92037 (858) 457-5300
TRANSDEL PHARMACEUTICALS INC (Issuer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address TRANSDEL PHARMACEUTICALS, INC. 4225 EXECUTIVE SQUARE, SUITE 460 LA JOLLA CA 92037
Business Address (858) 457-5300
Lomoro John T (Reporting) CIK: 0001421169 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52998 | Film No.: 08781841